Retiro De Equipo (Recall) de Flex Cocaine Reagent Cartridge on Dimension

Según L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en France que fue producido por DADE BEHRING.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • Fecha
    2006-03-23
  • País del evento
  • Fuente del evento
    ANSM
  • URL de la fuente del evento
  • Notas / Alertas
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Notas adicionales en la data
  • Acción
    On March 24, 2006, DADE BEHRING withdrew EJ6174 - FG6180 - CB6192 - FM6210 - CP6224 from the market for the in vitro diagnostic medical device called Flex Cocaine Reagent Cartridge on Dimension - Reference Analyzers DF 92A following the Highlighting. a decrease in the sensitivity of the technique at the level of the threshold value. This device is used for the detection of the urinary metabolite of cocaine .. The company DADE BEHRING directly warned the recipients of the incriminated lots by means of the attached message (24/03/2006) (20 KB) validated by the Afssaps . The competent European authorities concerned are informed directly by the manufacturer. This information is intended for laboratory managers, the directors of health establishments and the reactovigilance correspondents for dissemination, where appropriate, to the services concerned.

Device

  • Modelo / Serial
  • Descripción del producto
    in-vitro_medical_device
  • Manufacturer

Manufacturer

  • Source
    LAANSM